Accu-Chem Laboratories is well-known for over 24 years of experience in providing clinical, and occupational toxicological testing. The testing performed by Accu-Chem includes analyses of body fluids and tissues for recognized toxic chemicals including chlorinated pesticides, volatile solvents, and polychlorinated biphenyls (PCBs).
"We are excited about the acquisition of Accu-Chem Laboratories," says Dr. J. Alexander Bralley, CEO of Metametrix Clinical Laboratory. "Incorporating Accu-Chem testing into our current test offerings will allow us to offer a broader range of toxicological testing services to our clients, which will in turn help them offer more detailed treatment plans to their patients."
These tests, which will fall under the Toxic Effects Profiles, are beneficial for patients who have been exposed to toxic chemicals from various sources including work environments, toxic spills, and industrial land, air, and water pollutants.
For 25 years, Metametrix Clinical Laboratory has been an industry leader in producing innovative, Next Generation Technologies(SM) for measuring nutritional insufficiencies, metabolic dysfunction, as well as toxic influences on health. Metametrix is committed to applying the latest advances in testing services to functional and integrative medicine with a focus on quality, innovation, and education.
For Information: http://www.metametrix.com
